No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation

被引：0
|
作者：
Sachie Wada
Yuki Asano-Mori
Hisashi Yamamoto
Mitsuhiro Yuasa
Kosei Kageyama
Daisuke Kaji
Aya Nishida
Kazuya Ishiwata
Shinsuke Takagi
Go Yamamoto
Naoyuki Uchida
Akiko Yoneyama
Shigeyoshi Makino
Shuichi Taniguchi
机构：
[1] Toranomon Hospital,Department of Hematology
[2] Toranomon Hospital,Department of Clinical laboratory
[3] Toranomon Hospital,Department of Transfusion Medicine
来源：
Bone Marrow Transplantation | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：765 / 768
页数：3
相关论文
共 50 条
  • [31] Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant
    Sackett, Katie
    Cohn, Claudia S.
    Fahey-Ahrndt, Kayla
    Smith, Angela R.
    Johnson, Andrew D.
    JOURNAL OF CLINICAL APHERESIS, 2018, 33 (01) : 108 - 112
  • [32] Post-Transplant Isoagglutinin Induced Pure Red Cell Aplasia; Incidence and Clinic Outcomes
    Kochuparambil, Samith
    Litzow, Mark R.
    Hogan, William
    Hashmi, Shahrukh
    Gastineau, Dennis
    Patnaik, Mrinal
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S237 - S237
  • [33] Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation
    Khan, Fatima
    Linden, Michael A.
    Zantek, Nicole D.
    Vercellotti, Gregory M.
    BLOOD, 2013, 122 (21)
  • [34] Bortezomib: Successful treatment of refractory pure red cell aplasia after ABO-incompatible stem cell transplantation
    Lukic, Stefan
    Menzel, Helge
    Benk, Janka
    Sitskaya, Xenia
    Drewniock, Petra
    Basara, Nadezda
    BONE MARROW TRANSPLANTATION, 2019, 54 : 279 - 280
  • [35] Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation
    Busca, Alessandro
    Dellacasa, Chiara
    Giaccone, Luisa
    Manetta, Sara
    Biale, Lucia
    Godio, Laura
    Aydin, Semra
    Festuccia, Moreno
    Brunello, Lucia
    Bruno, Benedetto
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) : 1765 - 1770
  • [36] Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease
    M Yamaguchi
    K Sakai
    R Murata
    M Ueda
    Bone Marrow Transplantation, 2002, 30 : 539 - 541
  • [37] Successful treatment of pure red cell aplasia with a single low dose of rituximab in two patients after major ABO incompatible peripheral blood allogeneic stem cell transplantation
    Zhidong, W.
    Hongmin, Y.
    Hengxiang, W.
    TRANSFUSION MEDICINE, 2012, 22 (04) : 302 - 304
  • [38] Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease
    Yamaguchi, M
    Sakai, K
    Murata, R
    Ueda, M
    BONE MARROW TRANSPLANTATION, 2002, 30 (08) : 539 - 541
  • [39] PURE RED CELL APLASIA: RARE COMPLICATION OF ABO MISMATCHED ALLOGENIC BLOOD OR MARROW TRANSPLANT
    Mishra, P.
    Mahapatra, M.
    Seth, T.
    Saxena, R.
    Pati, H. P.
    Aggarwal, N.
    Gupta, N.
    VOX SANGUINIS, 2011, 101 : 23 - 24
  • [40] Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin
    A Santamaría
    A Sureda
    R Martino
    A Domingo-Albós
    E Muñiz-Díaz
    S Brunet
    Bone Marrow Transplantation, 1997, 20 : 1105 - 1107
12345